IRadimed Corporation
IRMD
$85.27
$0.520.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 19.34% | 16.87% | 13.73% | 10.80% | 10.38% |
| Total Depreciation and Amortization | 81.56% | 42.53% | 18.38% | -3.19% | -2.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 304.22% | 177.86% | 28.40% | 41.59% | -43.49% |
| Change in Net Operating Assets | -119.93% | -200.30% | -81.75% | 162.02% | 152.80% |
| Cash from Operations | 11.19% | -2.64% | 6.20% | 71.48% | 104.95% |
| Capital Expenditure | 60.89% | 3.00% | -78.54% | -476.10% | -769.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 39.05% | 19.20% | -23.93% | -52.27% | -34.23% |
| Cash from Investing | 59.42% | 4.49% | -73.02% | -389.61% | -535.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -85.12% | -85.12% | -83.59% |
| Repurchase of Common Stock | -237.14% | -272.26% | -35.72% | -30.60% | -18.51% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -96.29% | -9.97% | 28.78% | 17.73% | 1.42% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -109.11% | -22.78% | 24.92% | 13.82% | -1.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.11% | -143.48% | -3.43% | 64.46% | 121.51% |